DCM
GH icon

Driehaus Capital Management’s Guardant Health GH Stock Holding History

Driehaus Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141M Sell
1,524,282
-618,911
-29% -$62.1M 1.04% 13
2025
Q4 		$219M Sell
2,143,193
-9,122
-0.4% -$816K 1.49% 4
2025
Q3 		$134M Sell
2,152,315
-323,298
-13% -$17.6M 0.96% 12
2025
Q2 		$129M Buy
2,475,613
+542,527
+28% +$24.2M 1.03% 12
2025
Q1 		$82.3M Buy
+1,933,086
New +$83.4M 0.79% 25
2021
Q3 		– Sell
-65,614
Closed -$8.15M – 426
2021
Q2 		$8.15M Buy
65,614
+9,245
+16% +$1.24M 0.11% 242
2021
Q1 		$8.61M Sell
56,369
-24,307
-30% -$3.67M 0.13% 221
2020
Q4 		$10.4M Buy
80,676
+7,080
+10% +$815K 0.17% 174
2020
Q3 		$8.23M Buy
73,596
+34,707
+89% +$3.17M 0.17% 155
2020
Q2 		$3.15M Buy
38,889
+1,172
+3% +$94.4K 0.08% 232
2020
Q1 		$2.63M Sell
37,717
-11,949
-24% -$917K 0.09% 203
2019
Q4 		$3.88M Buy
49,666
+121
+0.2% +$8.72K 0.1% 210
2019
Q3 		$3.16M Sell
49,545
-1,368
-3% -$121K 0.1% 207
2019
Q2 		$4.39M Buy
50,913
+15,125
+42% +$1.16M 0.14% 176
2019
Q1 		$2.75M Sell
35,788
-54,209
-60% -$3.01M 0.1% 196
2018
Q4 		$3.38M Buy
+89,997
New +$3.32M 0.14% 169

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Driehaus Capital Management's GH Position: Q1 2026 in Review

Driehaus Capital Management reduced its Guardant Health (GH) stake by 29% in Q1 2026, selling an estimated $62.1M and leaving 1,524,282 shares worth $141M. The position accounts for 1.04% of the portfolio, ranked #13.

Driehaus Capital Management first reported a position in GH in Q4 2018 and has held it in 16 quarters since. The position peaked at $219M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Driehaus Capital Management held 1,524,282 shares of Guardant Health worth $141M as of Q1 2026.
  • Driehaus Capital Management sold 618,911 Guardant Health shares in Q1 2026, an estimated $62.1M.
  • Guardant Health made up 1.04% of Driehaus Capital Management's portfolio in Q1 2026, its #13 holding.
  • Driehaus Capital Management first reported a position in Guardant Health in Q4 2018 and has held it in 16 quarters since.
  • Driehaus Capital Management's Guardant Health position peaked at $219M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.